Costa, R.A., et al.
Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
Retina, 2007. 27(2): p. 141-9

Cugati, S., et al.
Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts.
Ophthalmology, 2007. 114(3): p. 520-4.

Kumagai, K., et al.
Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion.
Retina, 2007. 27(1): p. 49-54.

Lin, J.M., et al.
Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Retina, 2007. 27(2): p. 180-9.

Matsumoto, Y., et al.
Rebound macular edema following bevacizumab (avastin) therapy for retinal venous occlusive disease.
Retina, 2007. 27(4): p. 426-31.

Mohamed, Q., et al.
Interventions for central retinal vein occlusion: an evidence- based systematic review.
Ophthalmology, 2007. 114(3): p. 507-19, 524.

Spandau, U., et al.
Intravitreal bevacizumab for branch retinal vein occlusion.
Acta Ophthalmol Scand, 2007. 85(1): p. 118-9.

Yamaike, N., et al.
Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion.
Am J Ophthalmol, 2007. 143(2): p. 342-4.

Zheng, L., et al.,
Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes.
Invest Ophthalmol Vis Sci, 2007. 48(1): p. 361-7.